Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Northwest Biotherapeutics (NWBO) Other Operating Expenses (2016 - 2019)

Northwest Biotherapeutics' Other Operating Expenses history spans 9 years, with the latest figure at -$3.3 million for Q4 2019.

  • Quarterly results put Other Operating Expenses at -$3.3 million for Q4 2019, down 826.56% from a year ago — trailing twelve months through Sep 2020 was -$3.3 million (down 187.9% YoY), and the annual figure for FY2018 was $4.5 million, down 50.18%.
  • Other Operating Expenses for Q4 2019 was -$3.3 million at Northwest Biotherapeutics, down from $802000.0 in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $6.6 million in Q4 2015 to a low of -$3.3 million in Q4 2019.
  • The 5-year median for Other Operating Expenses is $1.5 million (2017), against an average of $1.6 million.
  • The sharpest move saw Other Operating Expenses skyrocketed 31433.33% in 2016, then tumbled 826.56% in 2019.
  • Year by year, Other Operating Expenses stood at $6.6 million in 2015, then plummeted by 76.48% to $1.5 million in 2016, then dropped by 2.33% to $1.5 million in 2017, then plummeted by 70.35% to $448000.0 in 2018, then tumbled by 826.56% to -$3.3 million in 2019.
  • According to Business Quant data, Other Operating Expenses over the past three periods came in at -$3.3 million, $802000.0, and $914000.0 for Q4 2019, Q3 2019, and Q2 2019 respectively.